Blood screening plays a vital role in identifying infectious agents and ensuring blood products are safe before transfusion. Increasing blood donations across hospitals and blood banks, combined with stronger regulatory focus on patient safety, continue to accelerate adoption of advanced screening technologies. The market also benefits from rising investments in diagnostic innovation and the need for faster, more accurate screening solutions across healthcare facilities.

The global Blood Screening Market Size is witnessing significant momentum as healthcare systems worldwide continue prioritizing blood safety, early disease detection, and reliable transfusion practices. According to The Insight Partners, the Blood Screening Market is expected to reach US$ 6.73 billion by 2031, registering a CAGR of 9.4% during 2025–2031. Growing emphasis on safe blood transfusions, advancements in screening technologies, and increasing awareness around infectious disease prevention are supporting long-term market expansion. As healthcare providers and blood banks strengthen screening protocols, the market is expected to remain a critical segment within global diagnostics.

Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00006182

Blood Screening Market Growth Outlook Through 2031

The blood screening market is projected to experience strong growth over the forecast period, supported by technological progress and increasing demand for high-quality diagnostic testing. Screening procedures are becoming more sophisticated, enabling healthcare institutions to improve safety while reducing testing turnaround time.

As blood transfusion demand continues rising globally, healthcare providers are focusing on screening technologies that can enhance detection accuracy and support operational efficiency. The market outlook remains positive as laboratories and blood banks continue integrating modern testing platforms to improve workflow and maintain compliance with blood safety requirements.

Key Trends Driving the Blood Screening Market

Technological Advancements in Blood Screening

Technology remains a major growth factor for the market. Continuous innovation in screening methods allows healthcare professionals to detect infections with improved sensitivity and reliability. These developments are strengthening trust in blood testing systems and encouraging wider adoption across healthcare settings.

Rising Focus on Blood Safety

Patient safety remains a top priority worldwide. Hospitals and blood banks continue implementing strict screening procedures to reduce transfusion risks and improve overall healthcare quality. This trend is expected to drive consistent market demand through 2031.

Growing Blood Donation Programs

Government and non-profit blood donation initiatives are increasing the availability of donated blood. With higher collection volumes, healthcare organizations require efficient and accurate screening systems, further supporting market growth.

Market Segmentation Analysis

The Blood Screening Market is segmented based on technology, product and service, and end user.

By Technology:

• Nucleic Acid Test (NAT)
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Western Blot Assay
• Next-Generation Sequencing (NGS)
• Rapid Tests

By Product and Service:

• Reagents and Kits
• Instruments
• Software
• Services

By End User:

• Hospitals
• Blood Banks

These segments highlight the broad application of blood screening technologies and demonstrate how healthcare institutions are investing in multiple screening platforms to improve patient outcomes.

Regional Market Insights

The Blood Screening Market continues expanding across major global regions including North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa.

North America remains a major contributor due to strong healthcare infrastructure and advanced screening adoption. Europe continues demonstrating steady demand supported by regulatory compliance and healthcare modernization. Asia Pacific is also emerging as a strong opportunity area as healthcare investments and blood donation awareness continue increasing.

Regional expansion is expected to remain an important contributor to overall market development through 2031.

Top Key Players in the Blood Screening Market

Leading companies operating in the Blood Screening Market include:

• BD
• Beckman Coulter, Inc.
• Thermo Fisher Scientific Inc.
• Siemens
• Bio-Rad Laboratories, Inc.
• Abbott
• F. Hoffmann-La Roche Ltd
• Grifols, S.A.
• bioMérieux SA

These market participants continue focusing on product innovation, strategic expansion, and advanced screening technologies to strengthen their competitive positioning and support industry growth.

Future Opportunities in the Blood Screening Market

The market is expected to benefit from increasing healthcare investments and rising demand for reliable blood safety solutions. Advanced screening technologies and expanding healthcare access are likely to create new growth opportunities for manufacturers and diagnostic providers.

As the healthcare industry places greater focus on preventive care and accurate diagnostics, blood screening is expected to remain essential for supporting clinical decision-making and maintaining transfusion safety worldwide.

Trending Reports:

·         Blood Culture Tests Market Growth, Demand & Size by 2034

·         Blood Culture System Market Trends, Demand & Growth by 2034

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.

Contact Us:
Contact Person: Ankit Mathur 
E-mail: [email protected]
Phone: +1-646-491-9876

Also Available in : Korean|German|Japanese|French|Chinese|Italian|Spanish